Annual Current Liabilities
$49.90 M
+$13.84 M+38.38%
31 December 2023
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares annual total current liabilities is currently $49.90 million, with the most recent change of +$13.84 million (+38.38%) on 31 December 2023. During the last 3 years, it has risen by +$34.14 million (+216.74%). NAMS annual current liabilities is now at all-time high.NAMS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$41.26 M
-$4.05 M-8.94%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares quarterly total current liabilities is currently $41.26 million, with the most recent change of -$4.05 million (-8.94%) on 30 September 2024. NAMS quarterly current liabilities is now -30.93% below its all-time high of $59.73 million, reached on 31 March 2024.NAMS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.4% | - |
| 3 y3 years | +216.7% | - |
| 5 y5 years | - | - |
NAMS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +346.1% | -30.9% | +268.8% |
| 5 y | 5 years | at high | +346.1% | -30.9% | +268.8% |
| alltime | all time | at high | +346.1% | -30.9% | +268.8% |
NewAmsterdam Pharma Company NV Ordinary Shares Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $41.26 M(-8.9%) |
| June 2024 | - | $45.31 M(-24.1%) |
| Mar 2024 | - | $59.73 M(+19.7%) |
| Dec 2023 | $49.90 M | $49.90 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $41.66 M(+15.5%) |
| Dec 2022 | $36.06 M(+222.3%) | $36.06 M(+33.3%) |
| June 2022 | - | $27.06 M(+141.9%) |
| Dec 2021 | $11.19 M(-29.0%) | $11.19 M |
| Dec 2020 | $15.75 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual total current liabilities?
- What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual current liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
What is NewAmsterdam Pharma Company NV Ordinary Shares annual total current liabilities?
The current annual current liabilities of NAMS is $49.90 M
What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high annual total current liabilities is $49.90 M
What is NewAmsterdam Pharma Company NV Ordinary Shares annual current liabilities year-on-year change?
Over the past year, NAMS annual total current liabilities has changed by +$13.84 M (+38.38%)
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly total current liabilities?
The current quarterly current liabilities of NAMS is $41.26 M
What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high quarterly total current liabilities is $59.73 M